Patient-reported Outcomes

Patient-reported outcomes (PROs) provide essential safety and tolerability data to inform clinical care and regulatory decisions; however, their use in early phase settings and integration with clinical and wearable data to target interventions is limited. Furthermore, trials using PROs often fail to address cultural or health specificities of under-served populations. This theme will address “unacceptable health inequalities” by facilitating participation in patient-centred research from under-served populations. PROs are particularly important in chronic/inflammatory disease, as improvements in clinical outcomes may be challenging to measure, and curative therapies not yet widely available. The target of intervention in these conditions may be to reduce symptom burden and improve quality of life.

Healthcare professional showing exam results to a patient

Theme Leads


Professor Mel Calvert


Associate Professor Lee Aiyegbusi

Related news

Toolkit helps researchers develop more equitable and representative research

Groups of people currently under-represented in clinical trials could benefit from improved health prospects – thanks

Patients with Atrial High-Rate Episodes should not be treated with anticoagulant, trial finds

A trial involving Birmingham researchers showed that patients with atrial high-rate episodes (AHREs) detected by implanted

New resources to improve patient and public involvement in health research

Patients and members of the public will be able to more easily take part in impactful